290 related articles for article (PubMed ID: 27074591)
21. Polymorphisms involving gain or loss of CpG sites are significantly enriched in trait-associated SNPs.
Zhou D; Li Z; Yu D; Wan L; Zhu Y; Lai M; Zhang D
Oncotarget; 2015 Nov; 6(37):39995-40004. PubMed ID: 26503467
[TBL] [Abstract][Full Text] [Related]
22. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
[TBL] [Abstract][Full Text] [Related]
23. Multi-omic analysis suggests tumor suppressor genes evolved specific promoter features to optimize cancer resistance.
Huang D; Wang X; Liu Y; Huang Z; Hu X; Hu W; Li Q; Chan H; Zou Y; Ho IHT; Wang Y; Cheng ASL; Kang W; To KF; Wang MHT; Wong SH; Yu J; Gin T; Zhang Q; Li Z; Shen J; Zhang L; Chan MTV; Liu X; Wu WKK
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33783485
[TBL] [Abstract][Full Text] [Related]
24. Convergence of evidence from a methylome-wide CpG-SNP association study and GWAS of major depressive disorder.
Aberg KA; Shabalin AA; Chan RF; Zhao M; Kumar G; van Grootheest G; Clark SL; Xie LY; Milaneschi Y; Penninx BWJH; van den Oord EJCG
Transl Psychiatry; 2018 Aug; 8(1):162. PubMed ID: 30135428
[TBL] [Abstract][Full Text] [Related]
25. Sequence context analysis of 8.2 million single nucleotide polymorphisms in the human genome.
Zhao Z; Zhang F
Gene; 2006 Feb; 366(2):316-24. PubMed ID: 16314054
[TBL] [Abstract][Full Text] [Related]
26. Allele-specific DNA methylation reinforces PEAR1 enhancer activity.
Izzi B; Pistoni M; Cludts K; Akkor P; Lambrechts D; Verfaillie C; Verhamme P; Freson K; Hoylaerts MF
Blood; 2016 Aug; 128(7):1003-12. PubMed ID: 27313330
[TBL] [Abstract][Full Text] [Related]
27. Predicting aberrant CpG island methylation.
Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12253-8. PubMed ID: 14519846
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
[TBL] [Abstract][Full Text] [Related]
29. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
[TBL] [Abstract][Full Text] [Related]
30. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
31. Cross-generational effects of alcohol dependence in humans on HRAS and TP53 methylation in offspring.
Hill SY; Rompala G; Homanics GE; Zezza N
Epigenomics; 2017 Sep; 9(9):1189-1203. PubMed ID: 28799801
[TBL] [Abstract][Full Text] [Related]
32. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
33. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
34. Prediction of DNA methylation in the promoter of gene suppressor tumor.
Saif I; Kasmi Y; Allali K; Ennaji MM
Gene; 2018 Apr; 651():166-173. PubMed ID: 29408272
[TBL] [Abstract][Full Text] [Related]
35. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis.
Qin Y; Liu JY; Li B; Sun ZL; Sun ZF
World J Gastroenterol; 2004 May; 10(9):1276-80. PubMed ID: 15112341
[TBL] [Abstract][Full Text] [Related]
36. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
[TBL] [Abstract][Full Text] [Related]
37. Plasma Triglyceride Levels May Be Modulated by Gene Expression of IQCJ, NXPH1, PHF17 and MYB in Humans.
Vallée Marcotte B; Guénard F; Cormier H; Lemieux S; Couture P; Rudkowska I; Vohl MC
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134766
[TBL] [Abstract][Full Text] [Related]
38. CpG methylation of APC promoter 1A in sporadic and familial breast cancer patients.
Debouki-Joudi S; Trifa F; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
Cancer Biomark; 2017; 18(2):133-141. PubMed ID: 27983523
[TBL] [Abstract][Full Text] [Related]
39. Genetic control of individual differences in gene-specific methylation in human brain.
Zhang D; Cheng L; Badner JA; Chen C; Chen Q; Luo W; Craig DW; Redman M; Gershon ES; Liu C
Am J Hum Genet; 2010 Mar; 86(3):411-9. PubMed ID: 20215007
[TBL] [Abstract][Full Text] [Related]
40. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
